Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 ILa | +7.14% | +7.14% | +15.38% |
Jun. 05 | Can-Fite Biopharma Ltd. Updates on Its Advanced Liver Cancer Pivotal Phase 3 Study | CI |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call |
Business Summary
Number of employees: 8
Sales per Business
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Sales per region
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 03-07-31 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Zivit Harpaz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Sari Fishman
PRN | Corporate Officer/Principal | 52 | 03-12-31 |
William D. Kerns
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 00-12-31 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Yaacov Goldman
BRD | Director/Board Member | 68 | 17-07-31 |
Guy Regev
BRD | Director/Board Member | 55 | 11-06-30 |
Yossi Bornstein
BRD | Director/Board Member | 66 | 21-08-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,497,128,493 | 1,496,706,120 ( 99.97 %) | 0 | 99.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 12.09M | |
+1.22% | 91.72B | |
0.00% | 39.44B | |
-8.52% | 34.47B | |
+64.13% | 26.7B | |
-17.37% | 15.13B | |
-5.99% | 13.27B | |
-10.69% | 11.74B | |
-47.78% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- CANF Stock
- Company Can-Fite BioPharma Ltd.